Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Cancer overtakes heart disease as leading cause of death in 22 U.S. states

Due to a sharp decrease in deaths resulting from cardiovascular disease, cancer has narrowed the gap and is challenging for the title of the nation’s number-one cause of mortality, according to research published online by the American Heart Association.

Thumbnail

Cost controls: Healthcare industry on a dangerous collision course

Two long-standing approaches to keeping healthcare costs down are on a “collision course” that could leave them both ineffective, according to a recent opinion piece in the New England Journal of Medicine. Do we have time to course correct or are we left to simply buckle our seatbelts and brace for impact?  

Thumbnail

Value-based payment modifier results: Less than 1% of groups earn bonuses

CMS has posted results from its implementation of the ACA’s value-based payment modifier program, and out of more than 13,800 eligible physician groups, just 128 groups—less than one percent—will receive “upward adjustments,” or bonuses, for strong performances. The rate for those adjustments is quoted as 15.92 percent, or 31.84 percent for some groups that treated high-risk beneficiaries.

5,500+ new, revised ICD-10 codes in the works for 2017

More than 5,500 diagnosis and procedures codes will be added to the ICD-10 coding system for fiscal year 2017.

Sentara names new president, CEO and COO

Howard P. Kern is the new president and CEO of Norfolk, Va.-based Sentara Healthcare as of March 4.

Skip the surgery and pop the placebo, writes cheeky surgeon-author

Any surgery carries risk, which is why decisions to put patients under the knife should be carefully considered. However, one surgeon is calling attention to the fact that some common procedures end up being about as effective as a placebo procedure would have been—and the placebo would have cost a lot less while doing the patient zero harm.

AMA, other orgs call for rejection of Aetna/Humana merger

The American Medical Association (AMA) has joined forces with the Florida Medical Association and Florida Osteopathic Medical Association, and written a letter to Florida Attorney General Pam Bondi, calling on her to reject the proposed merger of Aetna and Humana.  

Community Care of North Carolina wins inaugural Hearst Health Prize and $100,000

Community Care of North Carolina won the inaugural Hearst Health prize on March 8 and $100,000 for excellence in managing or improving health.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.